Lisinopril and Hydrochlorothiazide

Product NDC
68788-8155
11-digit product format
687888155
Labeler code
68788
Product ID
68788-8155_61bf7e99-adb8-4311-bc00-ed4e0ac2d05c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
Preferred Pharmaceuticals Inc.
Application
ANDA076194
Marketing category
ANDA
Marketing start
2022-03-17
Marketing end
0000-00-00
Substance
HYDROCHLOROTHIAZIDE; LISINOPRIL
Active strength
25 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
0J48LPH2THHYDROCHLOROTHIAZIDE58-93-5HYDROCHLOROTHIAZIDE
E7199S1YWRLISINOPRIL83915-83-7LISINOPRIL

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
68788-8155-168788815501100 TABLET in 1 BOTTLE, PLASTIC (68788-8155-1) 100 tablet2022-03-170000-00-00NoNoCurrent
68788-8155-36878881550330 TABLET in 1 BOTTLE, PLASTIC (68788-8155-3) 30 tablet2022-03-170000-00-00NoNoCurrent
68788-8155-66878881550660 TABLET in 1 BOTTLE, PLASTIC (68788-8155-6) 60 tablet2022-03-170000-00-00NoNoCurrent
68788-8155-96878881550990 TABLET in 1 BOTTLE, PLASTIC (68788-8155-9) 90 tablet2022-03-170000-00-00NoNoCurrent